Large screening of CA-MRSA among Staphylococcus aureus colonizing healthy young children living in two areas (urban and rural) of Portugal

May 11th, 2010

Tavares DA et al. – The results, based on analysis of S. aureus isolated from nasopharyngeal samples, suggest that in Portugal the prevalence of CA–MRSA carriage in healthy young children remains extremely low favoring the exclusion of this group as a reservoir of such isolates. read more

Trends in Antimicrobial Resistance of Acinetobacter baumannii Isolates from a Metropolitan Detroit Health System

May 5th, 2010

Reddy T et al. – Genotyping revealed polyclonality, suggesting either emergence of multiple resistant strains or spread of a common genetic element. The sharp rise mandates major multidisciplinary interventions to optimize management of this multidrug–resistant pathogen. read more

The Potential for Airborne Dispersal of Clostridium difficile from Symptomatic Patients

May 5th, 2010

Best EL et al. – Aerosolization of C. difficile occurs commonly but sporadically in patients with symptomatic CDI. This may explain the widespread dissemination of epidemic strains. The results emphasize the importance of single–room isolation as soon as possible after the onset of diarrhea to limit the dissemination of C. difficile. read more

Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia

May 5th, 2010

Alvarez CA et al. – Twenty–six CA–MRSA nosocomial infection–causing strains were detected in 250 MRSA infection isolates in mainly primary bacteremia and surgical site infections. The mortality related to nosocomial infection by CA–MRSA was 27%. read more

Drug susceptibility and clonality of methicillin-resistant Staphylococcus epidermidis in hospitalized patients with hematological malignancies

May 3rd, 2010

Nomura K et al. – The results represent two significant findings. One is the major capability of MRSE to colonize patients. The other is that some MRSE isolates proved to be sensitive to clindamycin, minocycline, and cephalosporin, so that using antibiotics to which MRSE is sensitive as first–line therapy can avoid the need for vancomycin in clinical settings. read more

Page 2 of 3«123»

Search